Shigeru Kondo Selected Research

Medulloblastoma

9/2012	Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility.
9/2012	Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeru Kondo Research Topics

Disease

4	Neoplasms (Cancer) 01/2023 - 09/2012
2	Medulloblastoma 09/2012 - 09/2012
1	Critical Illness (Critically Ill) 10/2023
1	Inflammation (Inflammations) 10/2023
1	Thrombosis (Thrombus) 10/2023
1	COVID-19 10/2023
1	Scoliosis 01/2023
1	Lennox Gastaut Syndrome 01/2021
1	Epilepsy (Aura) 01/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021

Drug/Important Bio-Agent (IBA)

2	Messenger RNA (mRNA)IBA 09/2012 - 09/2012
1	Monoclonal AntibodiesIBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	ProteomeIBA 10/2023
1	Complement Factor D (Factor D)IBA 10/2023
1	Complement Factor B (Factor B)IBA 10/2023
1	MineralsIBA 01/2023
1	soticlestatIBA 01/2021
1	TAK-441IBA 01/2014
1	HhAntag691IBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012
1	Transcription Factors (Transcription Factor)IBA 09/2012

Therapy/Procedure

1	Neck Dissection (Radical Neck Dissection) 01/2023
1	Glossectomy 01/2023